Open AccessPros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic
Author(s) -
Ayşe Bilge Öztürk,
Ayşe Baççıoğlu,
Özge Soyer,
Ersoy Civelek,
Sevim Bavbek
Publication year - 2021
Publication title -
astım allerji immünoloji
Language(s) - English
Resource type - Journals
ISSN - 1308-9234
DOI - 10.21911/aai.603
Subject(s) - nebulizer , pandemic , medicine , covid-19 , asthma exacerbations , exacerbation , asthma , intensive care medicine , coronavirus , disease , anesthesia , virology , infectious disease (medical specialty) , immunology , outbreak
Nebulizers generate aerosols and may potentially transmit respiratory viral particles including SARS-CoV-2. There is a great concern about the use of a nebulizer in the treatment of asthma exacerbations in the hospital or home setting during the COVID-19 pandemic and its use is not recommended unless essential. However, aerosol therapy should not be avoided in obligatory indications. Therefore, indications of nebulizer use during the pandemic should be evaluated on an individual basis in case of a severe asthma attack, and infection control recommendations should be followed by clinicians while using nebulizers. In this article, we aimed to assess the safety in addition to the “pro” and “con” sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic. Keywords: Asthma, coronavirus disease 2019, COVID-19, SARS-CoV-2, nebulizers